Andrew (Andy) Stamford, Ph.D., is Vice President, Chemistry, Deerfield Discovery and Development, and joined Deerfield in 2020. Prior to Deerfield, Dr. Stamford spent more than three years at Bridge Medicines as Vice President, Chemistry, and then as Senior Vice President of Research and Development. During this time, he also served as Vice President, Chemistry at the Tri-Institutional Therapeutics Discovery Institute. Dr. Stamford has over 25 years of combined experience at Merck and Schering-Plough Research Institute working in small molecule drug discovery from hit-to-lead to clinical candidate. He is the co-author of more than 70 peer-reviewed publications and an inventor on over 100 issued U.S. patents. Dr. Stamford holds a B.Sc. in Organic Chemistry from University of Tasmania and a Ph.D. in Organic Chemistry from University of Sydney.